Sound Growth Partners Invests in The BARS Program

EDMONDS, Wash.--(BUSINESS WIRE)-- Sound Growth Partners (“SGP”) is pleased to announce its majority recapitalization of BARS, LLC (“BARS”) on June 18, 2025. SGP provided all the capital required to complete the transaction via SGP’s One-Stop Buyout® structure.

Headquartered in Lakewood, CO, BARS is the leading provider of in-store, ID check compliance services for convenience and grocery stores in the U.S. and Canada. Founded in 1997, BARS has combined a mission-driven philosophy with best-in-class service to ensure its customers responsibly serve consumers.

“BARS has spent decades providing a unique and valuable service to tens of thousands of locations around the country,” said Travis Steele, Partner at SGP. “We appreciate the opportunity to partner with David Gaudet and Richard Wright and are excited about the future at BARS.”

To learn more about BARS, please visit https://www.barsprogram.com/.

About Sound Growth Partners

Founded in 2023, SGP is a Seattle-based private equity firm investing in clear market leaders within the lower middle market. SGP provides all the capital necessary to close a transaction. The firm invests in companies with $2 to $15 million of EBITDA in niches within the Consumer Products, Business Services, Distribution and Light Manufacturing industries.

To learn more about Sound Growth Partners and the One-Stop Buyout® structure, please visit https://soundgrowthpartners.com/ and follow us on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250624354151/en/

Kyle Largent, Managing Partner
[email protected]

Peter Roushdy, Managing Partner
[email protected]

Travis Steele, Partner
[email protected]

David Glazer, Partner
[email protected]

Source: Sound Growth Partners

You May Also Be Interested In

• CaringAI Presents Research at AAIC 2026 Showing Strong Clinician Agreement with AI-Powered Telephone Cognitive Screening
• GAC Group to Celebrate 30 Million Global Users on July 16
• Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress